Novo Nordisk A/S 2020 AR2
The report highlights Novo Nordisk's performance and sustainability achievements for the fiscal year 2020. Notably, the company achieved its target of using 100% renewable power across all global production sites. Additionally, Novo Nordisk launched its new 'Defeat Diabetes' social responsibility strategy to accelerate prevention and provide affordable care. Despite the challenges of the COVID-19 pandemic, the company expanded its global diabetes value market share to 29.3% and safely maintained its clinical trials.
Company: Novo Nordisk A/S
Sector: Manufacturing
Country: Denmark
Year: 2020
Type: AR2
Pages: 99
Back to company
Novo Nordisk A/S
Annual Report
The report highlights Novo Nordisk's performance and sustainability achievements for the fiscal year 2020. Notably, the company achieved its target of using 100% renewable power across all global production sites. Additionally, Novo Nordisk launched its new 'Defeat Diabetes' social responsibility strategy to accelerate prevention and provide affordable care. Despite the challenges of the COVID-19 pandemic, the company expanded its global diabetes value market share to 29.3% and safely maintained its clinical trials.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees